Neurology Edition: Top Headlines for Week of October 10, 2022

In this edition, preventive therapies should be offered for migraines; targeting neuropathic symptoms for poststroke pain; PDE5 inhibitors not associated with lower AD, dementia risk and more.

Read the full coverage here:

Range of preventive therapies should be offered for migraines

Poststroke pain may be controlled by targeting neuropathic symptoms

Treatment with PDE5 inhibitors not associated with reduced risk for AD, dementia

NFL, NFLPA finalize review of updated concussion protocol in wake of Tagovailoa injury

Blunt cerebrovascular injury increases risk for ischemic stroke, requires rapid response

References:

Bottros M. Poststroke pain: What it is, what causes it and how to treat it. Presented at: BRAINWeek; Sept. 28-30, 2022; Las Vegas.

Desai RJ, et al. Brain Commun. 2022;doi:10.1093/braincomms/fcac247.

Diamond M. Diamond Headache Clinic migraine track: Prevention, treatment. Presented at: BRAINWeek; Sept. 28-30, 2022; Las Vegas.

Press Release

Stone DK. Head and neck injury: Predictors of ischemic stroke. Presented at: BRAINWeek; Sept. 28-30, 2022; Las Vegas.